2018
DOI: 10.1016/j.jtbi.2018.04.040
|View full text |Cite
|
Sign up to set email alerts
|

The oscillatory boundary conditions of different frequency bands in Parkinson’s disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2019
2019
2019
2019

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 92 publications
0
2
0
Order By: Relevance
“…Oscillation activities, mainly including alpha (8–12 Hz), beta (11–30 Hz), delta (1–3 Hz), and theta (2–7 Hz)-frequency bands, are prominent features of the neuronal network and are closely related to many brain behavioral and functional states (Hutchison et al, 2004). Theta activity has been reported to lead to a paroxysmal increase in freezing behavior in PD patients (Follett and Torresrussotto, 2012; Hu et al, 2018). HCN channels reportedly contribute to theta frequency membrane resonance in hyperpolarized mammalian SNc neurons, which may be involved in theta oscillation (Xue et al, 2012).…”
Section: Hcn Channels Regulate the Electrical Activities Of Neurons Imentioning
confidence: 99%
“…Oscillation activities, mainly including alpha (8–12 Hz), beta (11–30 Hz), delta (1–3 Hz), and theta (2–7 Hz)-frequency bands, are prominent features of the neuronal network and are closely related to many brain behavioral and functional states (Hutchison et al, 2004). Theta activity has been reported to lead to a paroxysmal increase in freezing behavior in PD patients (Follett and Torresrussotto, 2012; Hu et al, 2018). HCN channels reportedly contribute to theta frequency membrane resonance in hyperpolarized mammalian SNc neurons, which may be involved in theta oscillation (Xue et al, 2012).…”
Section: Hcn Channels Regulate the Electrical Activities Of Neurons Imentioning
confidence: 99%
“…Currently, the pathogenesis of PD is still unclear (Carnwath et al, 2018), with a lack of an ideal therapeutic regimen in the clinic. According to most researchers, the primary pathologic changes of PD are that the degeneration and loss of dopaminergic neurons in the midbrain substantia nigra (SNc) cause the reduction of the dopamine (DA) release in the SNc—striatum pathway, the decrease of the direct pathway activity and the increase of the indirect pathway activity in the basal ganglia (BG), and the over-inhibition of thalamic and cortical neurons, which therefore lead to a clinical syndrome characterized by motor dysfunctions, such as bradykinesia, muscular rigidity, static tremor, gait disturbance, and postural instability (Ali and Morris, 2015; Hu et al, 2018; Stephano et al, 2018; Chen et al, 2019). Therefore, the main target for the treatment of PD is to deactivate the indirect pathway by enhancing dopaminergic neurotransmission or reducing glutamatergic neurotransmission.…”
Section: Introductionmentioning
confidence: 99%